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Background: Epidemiological studies have consistently shown that whole grain (WG) cereals can protect against
the development of chronic diseases, but the underlying mechanism is not fully understood. Among WG products,
WG rye is considered even more potent because of its unique discrepancy in postprandial insulin and glucose
responses known as the rye factor. In this study, an NMR-based metabolomics approach was applied to study
the metabolic effects of WG rye as a tool to determine the beneficial effects of WG rye on human health.
Methods: Thirty-three postmenopausal Finnish women with elevated serum total cholesterol (5.0-8.5 mmol/L)
and BMI of 20–33 kg/m2 consumed a minimum of 20% of their daily energy intake as high fiber WG rye bread (RB)
or refined wheat bread (WB) in a randomized, controlled, crossover design with two 8-wk intervention periods
separated by an 8-wk washout period. At the end of each intervention period, fasting serum was collected for
NMR-based metabolomics and the analysis of cholesterol fractions. Multilevel partial least squares discriminant
analysis was used for paired comparisons of multivariate data.
Results: The metabolomics analysis of serum showed lower leucine and isoleucine and higher betaine and
N,N-dimethylglycine levels after RB than WB intake. To further investigate the metabolic effects of RB, the serum
cholesterol fractions were measured. Total- and LDL-cholesterol levels were higher after RB intake than after
WB (p<0.05).
Conclusions: This study revealed favorable shifts in branched amino acid and single carbon metabolism and
an unfavorable shift in serum cholesterol levels after RB intake in postmenopausal women, which should be
considered for evaluating health beneficial effects of rye products.
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Whole grains (WG) are a rich source of fiber and bio-
active compounds, including tocopherols, B vitamins,
minerals, phenolic acids, and phytoestrogens [1]. There
is growing evidence that WG cereals protect against the
development of chronic diseases such as type 2 diabetes
(T2D) [2,3], cardiovascular disease (CVD) [4-6], and cer-
tain cancers [7-10]. WG rye, which is the traditional
WG bread consumed in northern Europe, is believed to
potentially exert even more positive effects than other
WG cereals due to the so-called ‘rye factor’ [11]. For
example, WG rye bread intake was the factor most
consistently associated with lower mortality in Danish
men in a recent prospective study with 12 years of
follow-up [12].
Postmenopausal women display decreased insulin
sensitivity, insulin secretion, and hepatic insulin extrac-
tion [13]. They therefore potentially have more pro-
nounced susceptibility to diabetes and CVD, which
makes them an interesting target population in examin-
ing the physiological effects of potentially protective
foods against CVD and T2D, such as WG rye. There is
growing evidence that T2D and related conditions are
characterized by a broad perturbation of metabolic
physiology involving considerable changes in lipid and
amino acid metabolism in addition to glucose [14]. This
new evidence is prompting the application of methods
monitoring a broad range of molecular species, i.e. meta-
bolomics, to study the beneficial effects of potentially
health-promoting foods.
The application of metabolomics to well-designed con-
trolled intervention studies can be a useful tool to eluci-
date the complex physiological effects of WG rye, which
might help in understanding their beneficial effects on
human health. Metabolomics has proven to be success-
ful in mechanistic understanding of beneficial health
effects of WG products using both NMR and LC/MS
approaches [15-18].
Lipidomics and GC-MS based metabolomics were
recently applied to compare the effects of a high-fiber
WG rye bread diet and a refined wheat bread diet on the
lipid and metabolic profiles of postmenopausal women
[16]. However, in view of the differences in the analytical
specificity of different platforms, the application of various
analytical platforms, i.e. lipidomics, LC-MS-based meta-
bolomics, and NMR, is necessary to expand the number
of detectable metabolites and thus achieve a more com-
prehensive understanding of modulation in metabolic pro-
file following an intervention.
Therefore the present study looked for further
changes in the serum metabolic profile of postmenopau-
sal women from the same intervention as reported
by our group [16,19] using the application of NMR-
based metabolomics.Methods
Human intervention
Forty-three postmenopausal women were recruited for
the intervention (18) through an advertisement in a local
newspaper. The inclusion criteria were: BMI 20–33 kg/m2,
serum total cholesterol concentration 5.0-8.5 mmol/L, non-
HDL cholesterol concentration 3.5-6.5 mmol/L, and
serum triglyceride concentration <2.5mmol/L. The exclu-
sion criteria included the use of lipid-lowering drugs,
laxatives, or corticosteroid medication. Women diagnosed
with diabetes mellitus were also excluded. Postmenopau-
sal status was confirmed by measuring the concentration
of follicle-stimulating hormone concentration in serum
(>30 U/L). All participants provided written informed
consent for the study and the study protocol was
approved by the Ethics Committee of Kuopio University
Hospital. Four women discontinued the study for per-
sonal or health reasons, so the final number of study sub-
jects was 39. However, serum samples were available for
only 33, so the data for metabolomics and cholesterol
analysis are reported for n = 33. The order of the test
bread intervention periods based on available serum
samples was WB-RB for 17 women and RB-WB for
16 women. At the beginning of the study, participants
(58.8 ± 5.8 years old) had body mass index (kg/m2) 27.2 ±
3.2, systolic blood pressure (mm Hg) 127.5 ± 17.9, and
diastolic blood pressure (mm Hg) 79.8 ± 8.3.
The study protocol is reported in detail in a previous
paper [19]. The present study was conducted in a rando-
mized crossover design with two 8-wk intervention periods
separated by an 8-wk washout period. The first interven-
tion period was preceded by a 2- to 3-wk run-in period
and afterwards participants were randomly assigned into
either an 8-wk high fiber rye bread (RB) period or an 8-wk
refined wheat bread (WB) period. At the beginning of the
run-in period, participants were advised to maintain their
lifestyle habits, regular medication, and body weight
throughout the study. They were also instructed to avoid
foods containing plant stanols/sterols, probiotics, or pro-
ducts that affect bowel function. During the washout
period, participants consumed their habitual diet. During
the intervention periods, a minimum of 20% of daily en-
ergy intake was provided by the test bread, while con-
sumption of other cereal products, such as sweet pastries
and porridges, was limited to 1 portion/d. A minimum of
4–5 portions of the test bread had to be eaten daily. Each
portion of rye bread weighed 24–28 g and each portion
of wheat bread 21–25 g. The high-fiber rye bread (RB)
(≈ 17% dietary fiber) was prepared by increasing the
content of rye bran in the breads, which caused a major
increase in the content of insoluble fiber. The nutrient
composition of the RB and WB used in the study was
analyzed at the Technical Research Centre of Finland
(VTT) and has been reported previously [19]. Four-day
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tive days) were kept during the run-in period and during
wk 4–6 in both bread intervention periods. Food
records were analyzed by a clinical nutritionist using
MicroNutrica dietary analysis software (version 2.0;
Finnish Social Insurance Institute).
Serum and plasma samples were collected from 12-h
fasting women at the end of the run-in and test bread
periods. Blood drawn from an antecubital vein was
collected in prechilled vacuum tubes to prepare serum.
The samples were stored in 2-mL cryotubes at −80°C
until analysis.
Metabolomics analysis
NMR-based metabolomics analysis of serum samples
collected at the end of each intervention period was per-
formed using previously described methods after slight
modification [15,20,21]. Nanosep centrifugal filters with
3 kDa cutoff (Pall Life Science, Port Washington, NY)
were washed 8 times with 0.5 mL water at 4000 g and
36°C to remove glycerol from the filter membrane.
The filters were kept at 4°C and then 400 μL of plasma
sample were filtered at 10,000 g and 4°C. Phosphate buffer
(150 μL, 0.4 mol/L, pH 7.0), D2O (45 μL) and sodium-
3-(trimethylsilyl)-2,2,3,3-tetradeuteriopropionate (TSP, 30
μL, 5.8 mmol/L) (Cambridge Isotope Laboratories, And-
over, MA) as an internal standard were added to 375 μL
plasma filtrate to ensure quantitative measurements of
metabolites captured by NMR. The mixture was then
used for NMR analysis. All NMR analyses of plasma
samples were performed on a Bruker spectrometer operat-
ing at 400 MHz (Karlsruhe, Germany). 1H NMR spectra
of plasma samples were obtained using zgesgp pulse se-
quence (Bruker Spectrospin Ltd.) at 25°C with 360 scans
and 32,768 data points over a spectral width of 4789.27
Hz. Acquisition time was 3.42 s and relaxation delay was
3.0 s. The discriminating NMR signals were identified pri-
marily using the NMR Suite 7.1 library (ChenomX Inc,
Edmonton, Canada), Human Metabolome Data Base,
Biological Magnetic Resonance Data Bank, and in the
event of multiplicity were confirmed with 2D NMR and
previously published data [22].
Biochemical analyses
Complementary biochemical analyses of cholesterol and
triglycerides in serum were performed to further investi-
gate the metabolic effects of RB. Serum samples col-
lected at the end of the run-in and test bread periods
were used for analysis of blood lipids. Lipoproteins were
separated by ultracentrifugation for 18 h at density 1.006
kg/L to remove the VLDL fraction. HDL in the infrana-
tant was separated from LDL by precipitation of LDL.
LDL was calculated as the difference between the mass
of cholesterol in the infranatant and HDL. Serum totalcholesterol and triglycerides were measured by an
enzymatic colorimetric method with commercial kits
(Monotest Cholesterol and Triglyceride GPO-PAP,
Boehringen Mannheim GmbH Diagnostica) using an
automated instrument (Kone Specific Clinical Analyzer,
Kone Ltd, Espoo, Finland). The within-assay CV for
triglycerides using 4 standards was 1.7-2.4% and the
between-assay CV was 1.3-1.6% (3 standards). The
corresponding values for HDL cholesterol were 1.4%
(1 standard) and 6.3% (1 standard).
Statistical analysis
The NMR spectral data were processed using Bruker
Topspin 1.3 software and were Fourier-transformed after
multiplication by a line broadening of 0.3 Hz and refer-
enced to TSP at 0.0 ppm. Spectral phase and baseline
were corrected manually. Each spectrum was integrated
using Amix 3.7.3 (Bruker BioSpin GmbH, Rheinstetten)
into 0.01 ppm integral regions (buckets) between 0.75-
8.5 ppm, in which areas between 4.25-6.75 ppm contain-
ing urea and residual water were removed. Each spectral
region was then normalized to the intensity of internal
standard (TSP).
PCA was performed using SIMCA-P+ 12.0.1 software
(UMETRICS, Umeå, Sweden) after centering and
pareto-scaling of the data as previously described [23].
In addition, MLPLS-DA was performed using Matlab
(version 2009a, MathWorks), and in-house written
Matlab routines [24,25] in order to account for the
crossover design and the possibility of pair-wise com-
parison of multivariate data in participants after RB and
WB treatments. MLPLS-DA can be considered a multi-
variate extension of a paired t-test that generates differ-
ent multivariate sub-models for between-subject and
within-subject variation (intervention effect) in the data
[24,25]. The advantage of this variation splitting is that
each submodel can be analyzed separately without being
confounded by the other source of variation. Rank prod-
uct provided by MLPLS-DA analysis was then used to
determine the most important NMR signals in the
multilevel classification model [24,25]. The multivariate
data were pareto-scaled by dividing each variable by the
square root of its standard deviation. The validity of
MLPLS-DA was tested by one thousand permutation to
determine the H0 distribution of no-effect (P<0.05)
[24,25]. The spectral variable with the highest PLS
regression coefficient is assigned the lowest rank product
(reported on logarithmic scale) and possesses the largest
discriminatory power [24,25] (Figure 1). The absolute
concentrations of the metabolites, which their corre-
sponding NMR signals were found discriminative in
MLPLS-DA, were calculated from the NMR spectra
using NMR Suite 7.1 profiler (ChenomX Inc, Edmonton,















Figure 1 Rank product (RP1/20) from multilevel partial least-squares discriminant analysis models of the comparsion between the NMR
spectra of serum after the intake of refined wheat bread vs the intake of whole grain rye bread in postmeopuasal women (n=33).
1: Isoleusine; 2: Leusine; 3: N,N-dimethylglycine; 4: Betaine; 5: an overlapping signal with glucose at 3.875 ppm; 6: small signal in an overlapping
area at 3.965 ppm. Chemical shift indicates the chemical shift of the spectral buckets used for multivariate analysis.
Moazzami et al. Nutrition Journal 2012, 11:88 Page 4 of 8
http://www.nutritionj.com/content/11/1/88overlapping signals. Paired t-test was then performed on
the absolute concentrations of four discriminative meta-
bolites between RB Vs WB [26]. Paired t-test as a uni-
variate approach does not take covariance between these
metabolites into account. The presence of outliers was
investigated using PCA-Hotelling T2 Ellipse (95% CI)
and the normality of multivariate data was investigated
using the normal probability plot of PCA model. The
multivariate data were normally distributed. The values for
absolute concentrations of the discriminative metabolites
between RB Vs WB were log-transformed before the
paired t-test when the distribution was skewed (Anderson-
Darling test, p<0.05).
Differences in energy, nutrient, and fiber intake and in
biochemical variables, between and within the test bread
periods, were analyzed with paired t-tests. All results are
expressed as mean ± SD. Differences were considered
statistically significant at p<0.05.Results
Overall, the participants complied well with the study.
Test bread intake exceeded the minimum number of
portions recommended during both bread periods (8 vs.
4 portions/day). Total energy and fat intake did not dif-
fer between the bread periods, while protein, carbohy-
drate, and dietary fiber intake was higher after RB than
after WB (p<0.05) (Table 1). Interestingly, at the end of
both RB and WB period, total fat, SFA, MUFA, and
PUFA intake was lower (p<0.05) than at the end of the
run-in period.MLPLS-DA was performed on the values of spectral
data (buckets) of each subject after RB Vs WB (n=33)
and was tested for the validity of the model (H0 distribu-
tion of no-effect-P<0.05). The absolute concentrations of
four metabolites, which their corresponding NMR signals
were found discriminative based on their rank product in
MLPLS-DA (Figure 1), were calculated from the NMR
spectra and further investigated by paired t-test (Table 2).
Plasma levels of leucine and isoleucine were lower and
plasma levels of betaine and N,N-dimethylglycine were
higher after RB than WB. Regarding the biochemical char-
acteristics of the postmenopausal women, total serum
cholesterol and LDL cholesterol levels were higher
(p<0.05) after RB than after WB (Table 3), while no sig-
nificant differences were observed between serum HDL
cholesterol and triglycerides after RB compared with
WB. A slight but significant reduction in body weight
(p<0.05) was observed within the RB group, but there
was no significant difference in body weight after RB
compared with WB.Discussion
Epidemiological studies have consistently shown that
WG cereals can protect against the development of
chronic disease, e.g. CVD and T2D [2-10,27]. How-
ever, the underlying molecular mechanisms linking
WG intake and the beneficial effects observed in epi-
demiological studies are not fully understood [27]. Meta-
bolomics has proven successful in explaining some of
the beneficial effects of WG products on health [15-18].
Table 1 Daily energy, macronutrient, and fiber intake by postmenopausal women during the run-in, high-fiber rye
bread (RB) and refined wheat bread (WB) periods, and test bread intake1
Run-in RB WB
Energy (MJ/d) 7.2 ± 1.5 7.5 ± 1.5 7.3 ± 1.5
Protein (% energy) 17.4 ± 3.2 18.4 ± 2.2a 17.3 ± 2.4
Total fat (% energy) 31.4 ± 6.3 27.9 ± 6.9b 28.9 ± 6.3b
SFA (% energy) 13.3 ± 3.5 11.4 ± 3.5b 11.3 ± 3.3b
MUFA (% energy) 10.4 ± 2.5 9.0 ± 2.9b 8.5 ± 2.8b
PUFA (% energy) 5.0 ± 1.1 3.5 ± 1.1b 3.6 ± 1.4b
Carbohydrates (% energy) 49.5 ± 6.9 52.8 ± 6.2a,b 52.5 ± 7.2b
Total dietary fiber (g) 24.2 ± 6.9 47.2 ± 9.1a,b 15.4 ± 4.0b
Insoluble dietary fiber (g) 11.01 ± 3.2 33.4 ± 6.5 a,b 6.2 ± 1.2b
Soluble dietary fiber (g) 5.6 ± 1.8 9.4 ± 1.9 a,b 4.9 ± 1.4b
Cholesterol (mg) 231 ± 111 228 ± 99 198 ± 84
Minimum amount of test breads to be consumed (g) 117 ± 18 103 ± 16
Test bread intake (g) 215 ± 47 180 ± 42
1Values are expressed as mean ± SD; n = 33. Intake was calculated from 4-d food records.a P<0.05 compared with WB; b P<0.05 compared with run-in (paired
t-test).
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WG can be achieved by evaluating the metabolic impact
of WG in different target populations. In the present
study, NMR-based metabolomics was used to study the
metabolic effects of intervention with rye bran-enriched
rye bread (RB) in postmenopausal women with slightly
elevated serum cholesterol. The overall aim was to eluci-
date the metabolic effects of RB in a new target group as
a mechanistic approach for further understanding the
beneficial effects of rye on health.
We used a quantitative NMR-based metabolomics
analysis in which the concentrations of the serum meta-
bolites were measured relative to an internal standard
(TSP). This approach improves the validity of findings
considering the reproducible nature of 1H-NMR analysis.
We used different approaches to confirm the identity ofTable 2 Results of the NMR-based metabolomics analysis of t
with rye and refined wheat breads1
Metabolite NMR signal (ppm)2 Rank produc
Isoleucine 0.924, 0.943, 0.965 54.9, -, -6
Leucine 0.952, 0.965 -, -6
Betaine 3.273 7.9
N,N-dimethylglycine 2.930 23.6
Leucine and Isoleucine levels were lower and betaine and N,N-dimethylglycine leve
refined wheat bread (control).
1 n = 33.
2NMR signals were identified using NMR Suite 7.1 library (ChenomX Inc, Edmonton,
Bank, spiking with an authentic standard, and confirmed with 2D NMR in the event
3The values of rank product are reported on a logarithmic scale [24] and referee to
4The absolute concentration of the metabolites in serum was calculated from area
Canada) and internal standard after correcting for overlapping signals.
5Paired t-test was performed on the absolute concentrations of the metabolites the
6Isoleucine and leucine possess common and separate NMR signals in a small spect
0.924-0.965 ppm were tested using paired t-test (P<0.05), when an isoleucine signa
7The p-value was calculated using log-transformed data.metabolites. In addition, all discriminating metabolites be-
tween RB and WB reported in the present study possess
well-cited NMR signals [22].
Effects of RB on branched amino acids
In the postmenopausal women studied, plasma levels of
two branched chain amino acids (BCAA) were lower
after intervention with RB than with WB. This is con-
sistent with previous findings by Lankinen et al. [17]
from metabolomics analysis in the FUNGENUT study,
where a reduction in isoleucine was observed in a rye
bread-pasta group compared with a parallel oat and
wheat bread-potato group after a 12-wk intervention.
Recently, two large independent longitudinal cohort
studies showed that high prospective plasma levels of
BCAA are significantly associated with future diabeteshe serum of postmenopausal women after intervention
t (NMR signal)3 Concentration (μmol/L)4
control vs rye
P-value5
65.7 ± 10.5 Vs 61.3 ± 9.8 0.005
128.9 ± 14.3 Vs 121 ± 13.5 0.007
24.9 ± 1.9 Vs 26.3 ± 3.1 0.005
3.27 ± 0.58 Vs 3.6 ± 0.90 0.0027
ls were higher after the intake of rye bread compared with the intake of
Canada), Human Metabolome Data Base, Biological Magnetic Resonance Data
of multiplicity.
NMR signals found discriminative using MLPLS-DA.
under their NMR signals using NMR Suite 7.1 profiler (ChenomX Inc, Edmonton,
ir NMR signals were found discriminative between two treatments.
ral region (0.924-0.965 ppm), and therefore all of their NMR signals between
l at 0.924 was detected as discriminative by MLPLS-DA (RP=54.9).
Table 3 Characteristics of the postmenopausal women before and after the RB and WB periods1
RB WB
Baseline Endpoint Baseline Endpoint
Body weight (kg) 69.9 ± 8.1a 69.5 ± 8.1 69.8 ± 8.2 69.7 ± 8.1
Serum total cholesterol (mmol/L) 6.5 ± 0.7a 6.8 ± 0.8b 6.5 ± 0.7 6.4 ± 0.7
Serum LDL-cholesterol (mmol/L) 4.3 ± 0.6 a 4.5 ± 0.8 4.2 ± 0.7 4.1 ± 0.6 b
Serum HDL-cholesterol (mmol/L) 1.7 ± 0.4 1.7 ± 0.4 1.7 ± 0.3 1.6 ± 0.3
Serum triglycerides (mmol/L) 1.3 ± 0.4 1.4 ± 0.5 1.3 ± 0.4 1.4 ± 0.4
1 Values expressed as mean ± SD; (n = 33);
a Significantly different from endpoint within group (p<0.05; paired t test);
b Significantly different from endpoint between groups (p<0.05; paired t test);
RB: high fiber rye bread, WB: refined wheat bread.
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risk of developing T2D, and plasma BCAA levels were
even predictive among subjects with similar fasting insulin
and glucose levels [28]. Interestingly, in the present study,
the lower plasma BCAA after RB occurred without any
significant differences in fasting insulin and glucose levels
between the high-fiber RB and WB treatments [19]. These
findings underscore the potentially positive effects of RB
in alleviating the recently reported metabolic risk factors
of T2D [28]. Supplementation studies with BCAA in ani-
mals and humans have indicated that circulating amino
acids may directly promote insulin resistance, possibly via
disruption of insulin signaling in the skeletal muscles. This
may be caused by activation of the mammalian target of
rapamycin, c-JUN, and insulin receptor substrate-1 signal-
ing in the skeletal muscles [29-32].
The known genetic risk factors of T2D add slightly
to the risk [33,34] and are associated with only a 5-37%
increase in the relative risk of diabetes, compared with
the 60-100% increase in risk that amino acids can pre-
dict [28]. This highlights the significance of final readout
of genetic and environmental factors in development of
T2D, which is reflected in the subject’s metabolic profile.
Our findings indicate that high-fiber RB intake poten-
tially causes a favorable shift in the metabolic profile
of postmenopausal women by reducing the levels of
some of circulating BCAAs known to be associated with
increased incidence of T2D.
Consumption of RB, either as endosperm or WG rye
bread, evokes a significantly lower postprandial insulin
response than intake of refined WB, without any change
in glycemia, an effect known as the ‘rye factor’ [35-39].
Repeated reduced insulin response has been associated
with reduced incidence of obesity and T2D [40]. In
obese and non-obese subjects, fasting concentration of
BCAA correlates with obesity and serum insulin. These
correlations between obesity, insulin, and BCAA may
support the notion that the lower BCAA observed in the
present study can be explained by reduced postprandial
insulin secretion during RB, a topic which warrants
further investigation [14].Higher levels of ketone bodies, reported in our pre-
vious intervention with rye products compared with
refined wheat products in prostate cancer patients [15],
were not observed in the present study. This might be
related to the much lower daily intake of rye products in
the present study than in the previous study (120 g/d
compared with 485 g/d), gender differences, and the
fact that the prostate cancer patients received 20% more
energy during intervention periods than baseline in
order to increase their rye intake [15].
Effect of RB on homocysteine and cholesterol
metabolism
Rye bran is a rich source of betaine [41], which may
explain the increased betaine levels after rye products
observed in the present and previous human and animal
studies [15,42,43]. Health beneficial effects of betaine
have been recently reported [44]. Betaine acts as a
methyl donor in the betaine-homocysteine methyl trans-
ferase reaction (BHMT-R), which converts homocysteine
and betaine to methionine and N,N-dimethylglycine
[45]. In the present study, we also observed an increase
in plasma N,N-dimethylglycine after the RB period,
which may indicate an increase in BHMT-R. Homocyst-
eine and methionine, the other metabolites involved in
this pathway, are present in low concentrations and have
overlapping signals with other metabolites on the NMR
spectrum, which obstructs their measurement by NMR.
The increase in betaine and N,N-dimethylglycine is con-
sistent with our recent findings in a metabolomics study
of the effect of WG rye intervention on prostate cancer
patients [15]. In that study, complementary targeted ana-
lysis of homocysteine in plasma showed that the increases
in betaine and N,N-dimethylglycine levels after intake of
rye products were accompanied by a reduction in plasma
homocysteine. However, in the present study targeted ana-
lysis of homocysteine in plasma was not possible for all
the subjects because non-availability of samples.
BHMT-R is catalyzed by betaine homocysteine methyl
transferase (BHMT), which is down-regulated by insulin
[46]. Therefore, the shift in BHMT-R after the RB period
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likely due to the rye factor [35-39], and to higher avail-
ability of betaine as a reaction precursor. Elevated circu-
lating homocysteine levels are an independent risk factor
for CVD [47-50]. In addition to the favorable effects
on BHMT-R, high betaine levels have been shown to
increase circulating LDL cholesterol and triacylglycerol
concentrations [50]. This may explain the higher levels
of total and LDL cholesterol after RB observed in the
present study in postmenopausal women with slightly
elevated circulating cholesterol levels. WG products
have high content of dietary fiber, which can potentially
reduce the reabsorption of bile acids from the intestine
and therefore increase bile acid biosynthesis from chol-
esterol, which may eventually reduce circulating choles-
terol levels. However, our findings suggest that the net
effect of betaine and dietary fiber in the modulation of
cholesterol levels after WG intake should be considered
and warrants further investigation [50].
Conclusion
The NMR metabolomics approach in the present study
revealed notable metabolic shifts related to changes in
BCAA and betaine-related metabolites (single carbon
metabolism) after an intervention with high-fiber RB in
postmenopausal women, a population group at risk of
developing T2D. These two metabolic pathways are
known to be associated with the development of chronic
disease. The changes in BCAA in the present study link
the potentially beneficial metabolic effects of RB to
metabolic pattern, which has been associated with the
development of T2D in large epidemiological studies.
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